West Pharmaceutical Services | WST - Operating Expenses


West Pharmaceutical Services reported $2.97B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Align Technology USD 821.72M 43.15M Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Dentsply International USD 1.36B 4M Sep/2026
Haemonetics USD 145.79M 448K Sep/2026
ICU Medical USD 501.85M 10.59M Sep/2026
Insulet USD 652.2M 19.8M Sep/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Neogen USD 224.6M 2.4M Jun/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 606.8M 39.4M Sep/2026
Repligen USD 185.01M 2.01M Sep/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 4.81B 5M Sep/2026
STAAR Surgical USD 77.95M 5.48M Sep/2026
Terumo JPY 331.37B 109.04B Sep/2026
Utah Medical Products USD 6.16M 447K Mar/2026
West Pharmaceutical Services USD 2.97B 22M Sep/2026